fucoxanthinol and Pancreatic-Neoplasms

fucoxanthinol has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for fucoxanthinol and Pancreatic-Neoplasms

ArticleYear
A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
    Nutrition and cancer, 2022, Volume: 74, Issue:1

    Fucoxanthin and its metabolite fucoxanthinol (FxOH), highly polar xanthophylls, exert strong anticancer effects against many cancer cell types. However, the effects of Fx and FxOH on pancreatic cancer, a high mortality cancer, remain unclear. We herein investigated whether FxOH induces apoptosis in human pancreatic cancer cells. FxOH (5.0 μmol/L) significantly promoted the growth of human pancreatic cancer PANC-1 cells, but induced apoptosis in human colorectal cancer DLD-1 cells. A microarray-based gene analysis revealed that the gene sets of cell cycle, adhesion, PI3K/AKT, MAPK, NRF2, adipogenesis, TGF-β, STAT, and Wnt signals in PANC-1 cells were markedly altered by FxOH. A western blot analysis showed that FxOH up-regulated the expression of integrin β1 and PPARγ as well as the activation of pFAK(Tyr

    Topics: Apoptosis; beta Carotene; Carotenoids; Cell Line, Tumor; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases

2022